Email updates

Keep up to date with the latest news and content from BMC Immunology and BioMed Central.

This article is part of the supplement: Proceedings of Delivery Systems and Current Strategies to Drug Design

Open Access Proceedings

New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity

Beatriz Tamargo, Yanet Márquez, Wendy Ramírez, Bárbara Cedré, Manuel Fresno and Gustavo Sierra*

BMC Immunology 2013, 14(Suppl 1):S12  doi:10.1186/1471-2172-14-S1-S12

Article Metrics

789
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 41 accesses
  • Last 365 days: 364 accesses
  • All time: 789 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information